drugset / Trial / NCT00414687

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

NCT00414687

Phase 2 Completed 63 enrolled Bayer
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the study drug is effective in the long-term treatment of primary or secondary pulmonary hypertension

Timeline

Start
1998-07
Primary completion
Completion
2001-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 4 ug Inhaled